Table 1.
Laboratory Data on the 42nd Day of the Alectinib Therapy.
| WBC | 7,180 | /μL | T-Bil | 1.85 | mg/dL | Fe | 48 | μg/dL | |||||
| RBC | 2.56×106 | /μL | LDH | 351 | U/L | ferritin | 879 | ng/mL | |||||
| Hb | 7.6 | g/dL | Alb | 2.2 | g/dL | UIBC | 122 | μg/dL | |||||
| MCV | 88.3 | % | BUN | 17.1 | mg/dL | CH50 | 36.8 | U/mL | |||||
| Ret | 47 | ‰ | Cre | 0.84 | mg/dL | C3 | 133 | mg/dL | |||||
| PLT | 42.3×104 | /μL | Na | 139 | mEq/L | C4 | 28 | mg/dL | |||||
| K | 3.3 | mEq/L | IgG | 1,678 | mg/dL | ||||||||
| AST | 21 | U/L | Cl | 93 | mEq/L | VB12 | 608 | pg/mL | |||||
| ALT | 12 | U/L | Ca | 8.4 | mg/dL | Folic acid | 6.6 | ng/mL | |||||
| ALP (JS) | 263 | U/L | CRP | 7.8 | mg/dL | Hpt | 86 | mg/dL | |||||
| γ-GTP | 13 | U/L | DAT | Positive | |||||||||
Alb: albumin, ALP: alkaline phosphatase, ALT: alanine aminotransferase, AST: aspartate aminotransferase, BUN: blood urea nitrogen, C3: complement 3, C4: complement 4, Ca: calcium, CH50: 50% hemolytic complement activity, Cl: chloride, Cre: creatinine, CRP: C-reactive protein, DAT: direct antiglobulin test, Fe: serum iron, Hb: hemoglobin, Hpt: haptogulobin, IgG: immunoglobulin G, JS: Japan Society of Clinical Chemistry, K: potassium, LDH: lactate dehydrogenase, MCV: mean corpuscular volume, Na: sodium, PLT: platelet, RBC: red blood cell, Ret: reticulocyte, T-Bil: total bilirubin, UIBC: unsaturated iron binding capacity, VB12: vitamin B12, WBC: white blood cell, γ-GTP: γ-glutamyl transpeptidase